{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-072792","form_type":"8-K","ticker":"HOOK","cik":"0001760542","company_name":"HOOKIPA Pharma Inc.","filed_at":"2024-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.937860+00:00","generated_at":"2026-06-01T03:56:20.077937+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"HOOKIPA shareholders approve doubling authorized shares and authorize reverse split","bullets":["Authorized common stock increased from 200M to 400M shares; approved by 64.8M for, 3.4M against.","Shareholders authorized board to implement reverse stock split (1:2 to 1:10) before June 17, 2025; 63.4M for, 4.7M against.","Directors Timothy Reilly and Malte Peters elected to Class II with 51.9M and 53.9M votes respectively.","Ratification of PwC Wirtschaftsprüfung GmbH as independent auditor for FY2024 approved (67.6M for)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-072792","json":"https://secwatch.observer/filing/0001104659-24-072792.json","markdown":"https://secwatch.observer/filing/0001104659-24-072792.md","text":"https://secwatch.observer/filing/0001104659-24-072792.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924072792/0001104659-24-072792-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924072792/tm2417487d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:56:20.077937+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}